Lancet

Article	Citations
Donald Bernard Longmore	10730
Interpreting COVID-19 data from China: a call for caution	3841
Human rights considerations are key when choosing a conference location	2642
Establishing equitable partnerships between the Global North and Global South	2559
The acknowledgment of death	1663
Miriam Mutebi: transforming breast cancer care in Africa	1511
Tonsillectomy for recurrent tonsillitis: the NATTINA trial	1486
Moderna stalls on African vaccine manufacturing plans	1464
Does TRIANGLE take down transplantation in mantle cell lymphoma?	1399
Hypertrophic cardiomyopathy secondary to hydroxychloroquine toxicity in a patient with rheumatoid arthritis	1348
Merrill Singer	1346
The injustice of tuberculosis	1312
Atosiban and managing women in preterm labour	1170
Prioritising maternal health must include care before pregnancy	1156
Political courage needed to prevent the next pandemic	1125
Hearing intervention and cognitive decline: the ACHIEVE trial	1098
Thinking outside of the tin box	1066
From disappointment to despair: USAID cuts to Myanmar's HIV services	950
A new drug for rare diseases: pozelimab for CHAPLE disease	923
Hypochondria, the ghost at medicine's feast	921
Department of Error	896
May Edward Chinn: pioneer of early cancer detection	870
Ronald Duncan Bradley	866
High-dose dual-antibiotic loaded bone cement in patients undergoing hemiarthroplasty	819
Israel border closure denying health care to Gazans	780

Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement	771
TRiP(cast) score and thrombosis risk for lower limb immobilisation – Authors' reply	763
Department of Error	759
Natural or artificial menstrual cycle for frozen embryo transfer	738
Beverly Malone: valuing diversity in nursing	726
Retraction: The first tissue-engineered airway transplantation: 5-year follow-up results	723
WHO EMRO's initiative on economic sanctions: delayed but promising	680
Physicians in the digital age	669
End compulsory drug treatment in the Asia-Pacific region	664
Understanding the potential and pitfalls of digital phenotypes to measure population mental health and wellbeing	661
Population health outcomes in Nigeria compared with other west African countries, 1998–2019: a systematic analysis for the Global Burden of Disease Study	650
Pandemics and the tourism industry: who is in control?	643
Department of Error	615
Neglected tropical diseases: ending the neglect of populations	604
Moving past the COVID-19 emergency in the USA	601
Calvarium indentations in multiple myeloma and CAR T-cell therapy	598
Nafis Sadik	597
Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine	597
Morphine for Gaza? Limits of care during genocidal violence	595
CoronaVac efficacy data from Turkey – Authors' reply	586
Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm	578
Something good enough	559
Australia to introduce sweeping e-cigarette regulations	558
“I am disabled, it doesn’t mean I have no dignity”	547
Offline: What have we done to medical students?	539
Characteristics of yoga providers and their sessions and students in the UK: a cross-sectional survey	538
Prominent skin folds of the scalp provide a superficial clue in acromegaly	528
Department of Error	523
Nigeria: health as a political prerequisite	512
Visa bureaucracy causing GPs to leave the UK	509
A fair day's wage for a fair day's work	485
Offline: Changing the argument for health	483
An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial	475
Anatomy teaching, dissection, and dignity of the dead	475
Department of Error	470
Visualising facial distortions in prosopometamorphopsia	469
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial	464
Threat level in the Gaza Strip: fatalities per 1000 person-years	456
Imagining alternative paths for WHO 75 years in	453
Remote haemodynamic monitoring in patients with heart failure – Authors' reply	450
Fluid retention and heart failure in the PRECISION trial – Authors' reply	445
Department of Error	442
Department of Error	437
Gaining MOMENTUM against anaemic myelofibrosis	435
Routine immunisations: reversing the decline	427
Human rights and health: a story of justice, hope, and resilience	426
Ophira Ginsburg: educating and empowering women with cancer	423
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma	423
Lowitja O'Donoghue	421
Associations between parental smoking and teenage alcohol and drug use in the Growing Up in Ireland cohort study: a longitudinal observational study	420

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors' reply	416
A high prostatic-specific antigen with a large pelvic mass indicates a prostatic cystadenocarcinoma	414
Knowledge and attitudes towards organ donation among students at An-Najah National University: a cross-sectional study	411
Treatment of vulnerable atherosclerotic plaques: the PREVENT trial	410
Primary health-care practices for deaf children should include early incorporation of a signed language	404
Türkiye rocked by newborn care scandal	402
South Korean doctors threaten mass resignation	396
Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use	395
HPV vaccination and cervical cancer screening	383
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, random	382
Improving children's lives—the case for universality	381
Nigeria's National Mental Health Act 2021: any challenges ahead?	379
Treatment of MSSA bacteraemia: a call for a personalised approach	378
Regional action needed to halt antimalarial drug resistance in Africa	376
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind	376
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches	365
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial	363
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial	363
Preventing cancer: the only way forward	362
The 2024 Lasker Awards	356
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised control	356
Pivotal points in the science of dementia risk reduction	355
Malaria vaccines: a test for global health	345
Childhood epilepsy	345
Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts	343
Offline: The unavoidable reckoning	339
Sanctions and the right to health in post-Assad Syria	338
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation	336
CAR T-cell perspectives in lupus – Authors' reply	334
“I'm losing faith in everything”: a qualitative study to understand barriers to accessing suitable mental health support for children and young people in Wales	330
“It's not about us anymore”: after the Le Scouarnec case	328
Colonoscopy versus faecal immunochemical testing in COLONPREV	324
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi	322
Legal accountability for climate change	322
Department of Error	319
Department of Error	318
Jenna Lester: advancing diversity in dermatology	317
Tackling heroin use in Mozambique	316
Lower respiratory tract infections in early childhood	312
A decolonised Commission agenda: the missing ingredients	312
Omicron: fewer adverse outcomes come with new dangers	306
Health at stake in Kenya elections	304
Protecting children from racism: urgent health system actions	304
Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis	302
Key questions regarding the SYMPLICITY HTN-3 trial	302
The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation	302
Changing gloves and switching instruments to decrease surgical site infection in abdominal surgery	299
Sackler money to go towards reducing overdose deaths	299
A new era for Africa CDC	299
Increasing humanitarian concerns for 2023	299
床前孝子	297
Anna Gilmore: confronting the commercial determinants of health	294
Offline: “I have no place to go”	293
Annabel Sowemimo: countering inequities in health care	290
Anthony Bryceson	290
Immediate versus delayed sequential bilateral cataract surgery	288
US plan to shield science from “inappropriate influence”	288
Orbital atherectomy for stent implantation: the ECLIPSE trial – Authors' reply	285
Perilous two-tier COVID-19 global vaccine roll-out	285
Protein provision during critical illness	284
Strikes	282
Use the remaining carbon budget wisely for health equity and climate justice	281
Tom Beauchamp	279
A taste of your own medicine: the experience of a transplant	278
Pembrolizumab for locally advanced cervical cancer	276
From innovation to impact in cardiovascular disease	274
Primary health care on the ballot in Australian election	270
Iscalimab 600 mg: justified or excessive? – Authors' reply	261
Can the FDA fulfil its mission with a smaller workforce?	261
To keep health as a unifying force, we must put resources into tackling health misinformation and disinformation	257
How can engagement with political science and international relations for health be improved?	257
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors' reply	257
Can COVID-19 help accelerate and transform the diagnostics agenda?	257
Reaching net zero carbon emissions in health systems	253
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?	252
Mpox: the need for a coordinated international response	251
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial	251
Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review	250
Brazil to start widespread dengue vaccinations	250
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance	249

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study	249
Racial inequities in homicide rates: Black women in the USA	247
Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial	247
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial	246
Health care under Milei	246
An age of uncertainty: mental health in young people	246
The health dimensions of violence in Palestine: a call to prevent genocide	245
On the quantification of military violence in Gaza	244
Mortality during migration through the Darién Gap in Panama in 2018–22	244
The road ahead for immediate kangaroo mother care in resource-constrained health systems	242
Realising transformative change in adolescent health and wellbeing: a second Lancet Commission	240
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial	239
Cervical cancers avoided by HPV immunisation	239
Resurgence of cholera amidst ongoing war in Sudan	238
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis	237
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial	236
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China	235
Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlle	234
Haemophilia	234
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets	234
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials	234
COVID-19 mRNA vaccination and myocarditis or pericarditis	233
Report of the Lancet Commission on the Value of Death: bringing death back into life	233
The pathogenesis of Parkinson's disease	233
Offline: Political declarations—clichés and lies	233
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Bur	232
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial	231
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes	229
Health and development from preconception to 20 years of age and human capital	228
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)	228
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study	224
Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial	223
Shakuntala Thilsted: shifting our approach to food systems	221
Public health and gun violence	220
Loiasis: bringing an end to neglect	217
The R21/Matrix-M malaria vaccine: questions remain	213
Hospitals as tenants: the rise of real estate investment trusts in health-care delivery	213
On going backwards	212
Private actors and governance for planetary health equity	212
How do homeless service users view their own health and healthcare? An ethnographic study	211
Traditional Chinese medicine for acute intracerebral haemorrhage	211
Co-production of a stakeholder workshop to inform multimorbidity prevention research: working with public contributors to ask the right questions (the MELD-B experience)	210
Policy and legislative approaches to address the social determinants of violence against children: an umbrella review.	209
Ticagrelor monotherapy for acute coronary syndromes – Authors' reply	208
Assessing adherence to Government's sugar, salt, and calorie reduction targets of the top 20 UK restaurants' menus in 2024: a cross-sectional study	208
Warnings over misuse of psychiatry in Russia	206
Long-term efficacy and public health implications of the Vi-tetanus toxoid conjugate vaccine in Bangladeshi children	206
Shirin Heidari: towards gender equity in health research	205
Irrigation efficacy in CSDH surgery: the FINISH trial – Authors' reply	204
A programme for greater health equity for the next UK Government	203
Opioids for back and neck pain: the OPAL trial	202
Mechanical circulatory support for cardiogenic shock	200
Unanswered questions from the IRONMAN trial	197
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke	197
Optimal usage of antibacterial sutures for wound closure in clinical trials addressing SSI – Authors' response	196
Recommitting to global solidarity: introducing the Kigali Call to Action	193
Infectious diseases in 2025: a year for courage and conviction	191
Racism and the health system	191
Calls for the Olympics to end harmful Coca-Cola sponsorship	191
Why aren't the Republicans talking about health?	190
Protecting the blood donor: ferritin-based intervals to improve donor health	189
An urgent case for measles vaccination in Gaza	187
The structural roots of violence against female health workers	186
Opening the door to widespread iPSC-derived regenerative therapy for corneal epithelial opacity	185
Accelerating domestic investments to end AIDS in Africa	185
Breastfeeding and the role of the commercial milk formula industry – Authors' reply	185
The USA and the plight of children in a humanitarian crisis	184
Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice	184
Time to fast-track interventions to road traffic crises in Iran	183
Department of Error	182
Department of Error	180
Antimicrobial resistance in carceral settings	180
Investing in adolescent health and wellbeing to secure sustainable progress	179
Wolves and women's bodies	178
Global HIV targets: a roadmap to 2030 and beyond	178
Assessing worldwide trends of underweight and obesity	177
Assessing worldwide trends of underweight and obesity – Authors' reply	177
Sparsentan and kidney protection: improved medullary oxygenation?	177
Efficacy of typhoid conjugate vaccine in Malawian children – Authors’ reply	177
Emodepside against hookworm	176
Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab	176
Health organisations welcome US climate crisis law	176
Naegleria fowleri in Kerala, India: prevention over panic	175
Drug-coated balloon angioplasty and stenting for coronary artery lesions	175
Kangaroo mother care before stabilisation: the OMWaNA trial	174
The Health Index: a framework to guide health-driven prosperity	174
Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 wome	173
Libby Sallnow: the gentle disruptor	173
By any means necessary: why lowering insulin prices is relevant to racial health equity	172
The nuclear threat: policy, science, and public opinion	171
Offline: Help us, please	171
One Health: a call for ecological equity	170
Offline: “My brothers and sisters in Israel and Palestine”	170
Error in NHS England's BMI calculator and daily calorie recommendations	170
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial	169